Expert Opinion on Emerging Drugs

Papers
(The H4-Index of Expert Opinion on Emerging Drugs is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Emerging drugs for hemophilia A: insights into phase II and III clinical trials69
Emerging therapeutics in Huntington’s disease25
Emerging immune tolerance therapies for neuromyelitis optica spectrum disorder22
Emerging and traditional 5-α reductase inhibitors and androgen receptor antagonists for male androgenetic alopecia18
Combined chemo-immunotherapy in advanced non-small cell lung cancer: feasible in the elderly?18
New drugs targeting calcitonin gene-related peptide for the management of migraines15
A review of phase II and III drugs for the treatment and management of endometriosis15
Emerging drugs for the treatment of postsurgical pain13
Evolving role of VIADISC for chronic low back and discogenic pain: a narrative review13
Emerging drugs for the treatment of acne: a review of phase 2 & 3 trials13
Emerging medicines to improve the basic defect in cystic fibrosis12
Muscarinic M1 and M4 agents as treatments for schizophrenia: what do they do and who do they do it for?12
0.019511938095093